Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q2 2018 · 10-Q
Revenue$12.35M$12.35M+202.5% vs Q2 2017 Net Income$3.19M$3.19MN/M vs Q2 2017 EPS Diluted$0.03$0.03N/M vs Q2 2017 Gross Profit$9,060,000+218.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flowderived$3,715,000+1,979.0% Free Cash Flowderived$3,663,000+2,026.2% Margins · derivedGross margin73.4%+3.7 pt vs Q2 2017
Operating margin26.7%+47.8 pt vs Q2 2017
Net margin25.8%+50.1 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 1, 2018 · 32 d after period end